FOR IMMEDIATE RELEASE
22nd November 2019
Paola - Malta
Cannapharm Technologies Malta Limited (“CPTM” or the “Company”) was present at the MedCann World Forum in Malta, 19th – 21st of November 2019.
The Medical Cannabis World Forum brought together global industry experts and professionals for a three-day conference on the island of Malta, focused on Legislation, Business, Regulatory, Education & Research.
CPTM's Chief Genetics Engineer, Gilad Livni, presented an updated outlook at Medical Cannabis breeding, in a presentation entitled "Practical Breeding".
Watch the full presentation here.
Bruce H. Gaston
Cannapharm Technologies Malta Limited (CPTM) is a limited company, registered under the Companies Act, 1995 of the Republic of Malta.
CPTM believes in long-term, incremental growth, based on the latest technological advances. It works closely with governments, regulatory authorities and local municipalities, to utilise, integrate and grow existing local infrastructures, within the framework of regional and governmental development programs and targets.
As an EU-based enterprise, CPTM adheres to and implements the strictest of standards in its productions, whilst maintaining a result-driven, qualitative approach to its pharmaceutical operations in Europe and Asia.